Future Oncology,
Год журнала:
2025,
Номер
unknown, С. 1 - 21
Опубликована: Фев. 12, 2025
Triple-negative
breast
cancer
(TNBC)
presents
a
formidable
global
health
challenge,
marked
by
its
aggressive
behavior
and
significant
treatment
resistance.
This
subtype,
devoid
of
estrogen,
progesterone,
HER2
receptors,
largely
relies
on
stem
cells
(BCSCs)
for
progression,
metastasis,
recurrence.
BCSCs,
characterized
their
self-renewal
capacity
resistance
to
conventional
therapies,
exploit
key
surface
markers
critical
signaling
pathways
like
Wnt,
Hedgehog,
Notch,
TGF-β,
PI3K/AKT/mTOR
Hippo-YAP/TAZ
thrive.
Their
adaptability
is
underscored
mechanisms
including
drug
efflux
enhanced
DNA
repair,
contributing
poor
prognosis
high
recurrence
rates.
The
tumor
microenvironment
(TME)
further
facilitates
BCSC
survival
through
complex
interactions
with
stromal
immune
cells.
Emerging
therapeutic
strategies
targeting
BCSCs
-
ranging
from
immunotherapy
nanoparticle-based
delivery
systems
gene-editing
technologies
aim
disrupt
these
resistant
Additionally,
innovative
approaches
focusing
exosome-mediated
metabolic
reprogramming
show
promise
in
overcoming
chemoresistance.
By
elucidating
the
distinct
characteristics
role
TNBC,
researchers
are
paving
way
novel
treatments
that
may
effectively
eradicate
resilient
cells,
mitigate
ultimately
improve
patient
outcomes.
review
highlights
urgent
need
targeted
address
unique
biology
pursuit
more
effective
interventions
TNBC.
Sains Malaysiana,
Год журнала:
2024,
Номер
53(3), С. 667 - 679
Опубликована: Март 20, 2024
Cancer
stem
cells
(CSCs)
are
a
small
population
of
tumour
that
responsible
for
initiation,
metastases,
recurrence,
and
resistance
to
conventional
therapy.
Hence,
targeting
CSCs
is
crucial
in
the
fight
against
cancer.
SF1,
standardised
fraction
from
Clinacanthus
nutans
leaf
extract,
has
been
reported
exhibit
potent
selective
antineoplastic
effects
cervical
cancer
cells.
In
this
study,
potential
SF1
inhibit
stemness
stem-like
evaluated.
extraction
was
carried
out
using
dry
column
vacuum
chromatography
technique.
SiHa
cell
lines
were
cultured
as
spheres
CSC-conditioned
medium
(cervospheres),
IC50
cervospheres
determined
OZBlue
Cell
Viability
Kit.
The
on
cervosphere’s
markers,
including
CD49f,
CK17,
SOX2,
OCT4,
NANOG,
assessed
flow
cytometry
assay.
Self-renewal
inhibition
anti-tumorigenesis
evaluated
sphere
formation
assay
xenograft
mouse
model.
present
study
shows
treatment
at
an
17.07
µg/mL
inhibited
proliferation,
self-renewal,
tumorigenic
capacity
vitro
vivo.
A
decrease
expressions
OCT4
indicated
SF1’s
inhibitory
also
associated
with
suppression
markers.
These
results
suggest
possesses
antitumor
effect
may
be
regarded
promising
approach
development
targeted
anticancer
agents
Cancers,
Год журнала:
2025,
Номер
17(3), С. 382 - 382
Опубликована: Янв. 24, 2025
Cancer
stem
cells
(CSCs)
play
a
central
role
in
tumor
progression,
recurrence,
and
resistance
to
conventional
therapies,
making
them
critical
focus
oncology
research.
This
review
provides
comprehensive
analysis
of
CSC
biology,
emphasizing
their
self-renewal,
differentiation,
dynamic
interactions
with
the
microenvironment
(TME).
Key
signaling
pathways,
including
Wnt,
Notch,
Hedgehog,
are
discussed
detail
highlight
potential
as
therapeutic
targets.
Current
methodologies
for
isolating
CSCs
critically
examined,
addressing
advantages
limitations
advancing
precision
medicine.
Emerging
technologies,
such
CRISPR/Cas9
single-cell
sequencing,
explored
transformative
unraveling
heterogeneity
informing
strategies.
The
also
underscores
pivotal
TME
supporting
survival,
promoting
metastasis,
contributing
resistance.
Challenges
arising
from
CSC-driven
dormancy
analyzed,
along
strategies
mitigate
these
barriers,
novel
therapeutics
targeted
approaches.
Ethical
considerations
integration
artificial
intelligence
designing
CSC-specific
therapies
essential
elements
future
manuscript
advocates
multi-disciplinary
approach
that
combines
innovative
advanced
therapeutics,
collaborative
research
address
complexities
CSCs.
By
bridging
existing
gaps
knowledge
fostering
advancements
personalized
medicine,
this
aims
guide
development
more
effective
cancer
treatment
strategies,
ultimately
improving
patient
outcomes.
Journal of Asian Natural Products Research,
Год журнала:
2025,
Номер
unknown, С. 1 - 13
Опубликована: Фев. 22, 2025
Esculetin
is
a
coumarin
compound
with
anticancer,
antioxidant,
and
anti-inflammatory
activities.
In
this
study,
we
synthesized
an
esculetin
derivative,
6,7-bis(Pentyloxy)-2H-Chromen-2-One
(BPCO),
through
etherification.
BPCO
inhibited
the
proliferation
of
HepG2
cells
in
dose-
time-dependent
manner.
It
also
cell
migration,
promoted
apoptosis,
caused
cycle
arrest
at
G1
phase.
Additionally,
downregulated
expression
levels
Bcl-2
Bcl-XL
upregulated
Bax
Bak.
This
study
shows
that
inhibits
hepatocellular
carcinoma
induces
providing
basis
for
further
as
antitumor
agent.
Cancers,
Год журнала:
2022,
Номер
14(10), С. 2408 - 2408
Опубликована: Май 13, 2022
The
importance
of
defining
new
molecules
to
fight
cancer
is
significant
interest
the
scientific
community.
In
particular,
it
has
been
shown
that
stem
cells
(CSCs)
are
a
small
subpopulation
within
tumors
with
capabilities
self-renewal,
differentiation,
and
tumorigenicity;
on
other
side,
circulating
tumor
(CTCs)
seem
split
away
from
primary
appear
in
circulatory
system
as
singular
units
or
clusters.
It
becoming
more
important
discover
biomarkers
related
these
populations
combination
define
network
among
them
microenvironment.
cancer-associated
fibroblasts
(CAFs)
key
component
microenvironment
different
functions,
including
matrix
deposition
remodeling,
extensive
reciprocal
signaling
interactions
crosstalk
immunity.
settings
markers
definition
molecular
connections
may
present
avenues,
not
only
for
fighting
but
also
tailored
therapies.
Stem Cell Reviews and Reports,
Год журнала:
2022,
Номер
18(7), С. 2209 - 2233
Опубликована: Июль 25, 2022
The
physiological
state
of
the
tumor
microenvironment
(TME)
plays
a
central
role
in
cancer
development
due
to
multiple
universal
features
that
transcend
heterogeneity
and
niche
specifications,
like
promoting
progression
metastasis.
As
result
their
preponderant
involvement
growth
maintenance
through
several
microsystemic
alterations,
including
hypoxia,
oxidative
stress,
acidosis,
TMEs
make
for
ideal
targets
both
diagnostic
therapeutic
ventures.
Correspondingly,
methodologies
target
have
been
investigated
this
past
decade
as
stratagems
significant
potential
genre
focused
treatment.
Within
targeted
oncotherapy,
nanomedical
derivates-nanocarriers
(NCs)
especially-have
emerged
present
notable
prospects
enhancing
targeting
specificity.
Yet,
one
major
issue
application
NCs
microenvironmental
directed
therapy
is
are
too
broad
spectrum
possibilities
these
carriers
be
effectively
employed.
However,
stem
cells
(CSCs)
might
portend
solution
above
conundrum:
aside
from
being
quite
heavily
invested
tumorigenesis
resistance,
CSCs
also
show
self-renewal
fluid
clonogenic
properties
often
define
specific
TME
niches.
Further
scrutiny
relationship
between
points
towards
mechanisms
underly
tumoral
characteristics
metastasis,
malignancy,
even
resistance.
This
review
summarizes
recent
advances
NC-enabled
more
holistic
strikes
against
discusses
current
challenges
hinder
clinical
strategies
well
avenues
can
further
CSC-targeting
initiatives.
Central
regulation
cellular
components
within
TME.
Cells,
Год журнала:
2023,
Номер
12(16), С. 2083 - 2083
Опубликована: Авг. 17, 2023
Head
and
neck
squamous
cell
carcinoma
(HNSCC)
is
the
sixth
leading
malignancy
worldwide,
with
a
poor
prognosis
limited
treatment
options.
Molecularly
targeted
therapies
for
HNSCC
are
still
lacking.
However,
recent
reports
provide
novel
insights
about
many
molecular
alterations
in
that
may
be
useful
future
therapies.
Therefore,
it
necessary
to
identify
new
biomarkers
better
prediction
of
disease
promising
targets
personalized
therapy.
The
response
therapy
attributed
small
population
tumor
cells
called
cancer
stem
(CSCs).
Growing
evidence
indicates
Hedgehog
(HH)
signaling
pathway
plays
crucial
role
development
maintenance
head
tissues.
HH
normally
involved
embryogenesis,
renewal,
tissue
regeneration.
abnormal
activation
also
associated
carcinogenesis
CSC
regulation.
Overactivation
was
observed
several
tumors,
including
basal
carcinoma,
successfully
treated
inhibitors.
clinical
studies
pathways
rare.
In
this
review,
we
summarize
current
knowledge
advances
regarding
discuss
its
possible
implications
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
173, С. 116403 - 116403
Опубликована: Март 15, 2024
Drug
resistance
(DR)
is
one
of
the
challenges
in
treating
retinoblastoma
(Rb)
that
warrants
novel
approaches.
With
emerging
evidence
on
role
small
extracellular
vesicles
(sEVs)
as
a
drug-delivery
carrier
system,
this
study,
we
derived
drug-resistant
clones
Y79
cells
and
evaluated
efficacy
sEVs-loaded
with
carboplatin
(sEVs-CPT)
to
reverse
chemoresistance.
Drug-resistant
(DR-Y79)
were
systematically
developed
through
sequential
exposure
(CPT),
showcasing
sixfold
increase
inhibitory
concentration
when
compared
parental
(IC50:
41.4
µg/mL
6.2
µg/mL)
(P<0.0001).
These
DR-Y79
show
higher
expression
ABCG2
DR
genes
than
The
sEVs
isolated
from
conditioned
media
using
ultracentrifugation
(UC)
characterized.
Further,
loaded
CPT
achieved
encapsulation
efficiency
at
hour,
drug
release
sEVs-CPT
was
highest
∼80%
pH
5.0.
cytotoxicity
3.5
vs
µg/mL;
23.1
41.2
(p<0.0001).
This
study
demonstrates
generates
cells,
which
could
serve
an
appropriate
model
evaluate
drugs.
highly
effective
enhancing
appear
hold
promise
complimentary
delivery
system.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(5), С. 2353 - 2353
Опубликована: Март 6, 2025
Tongue
squamous
cell
carcinoma
(TSCC),
a
subtype
of
head
and
neck
carcinoma,
is
characterized
by
frequent
chemoresistance.
Genetic
mutations
commonly
observed
in
TSCC
play
critical
role
malignant
progression;
thus,
elucidating
their
functional
significance
essential
for
developing
effective
treatment
strategies.
To
more
accurately
investigate
the
relationship
between
chemoresistance,
we
established
low-passage
cells,
CTSC-1,
obtained
from
chemoresistant
patient,
CTSC-2,
treatment-naïve
patient.
Sanger
sequencing
revealed
specific
TP53
mutation
(Q331*)
leading
to
loss
tetramerization
C-terminal
regulatory
domains.
Notably,
CTSC-1
cells
harboring
TP53-Q331*
CTSC-2
with
knockout
that
have
been
engineered
ectopically
express
exhibit
enhanced
chemoresistance
increased
cancer
stem
cell-like
properties.
Mechanistically,
upregulates
expression
inhibitor
DNA
binding
2
(ID2),
which
crucial
maintaining
stemness
cells.
Subsequently,
ID2
activates
nucleotide
excision
repair
(NER)
pathway-related
genes
ERCC4
ERCC8,
thereby
enhancing
TSCC.
In
conclusion,
our
study
demonstrates
enhances
through
an
ID2-mediated
NER
pathway,
providing
potential
prognostic
marker
therapeutic
target
chemotherapy
resistance.
Cells,
Год журнала:
2025,
Номер
14(7), С. 511 - 511
Опубликована: Март 29, 2025
Oxidative
stress
(OS)
is
an
established
hallmark
of
cancer
and
neurodegenerative
disorders
(NDDs),
which
contributes
to
genomic
instability
neuronal
loss.
This
review
explores
the
contrasting
role
OS
in
stem
cells
(CSCs)
NDDs.
Elevated
levels
reactive
oxygen
species
(ROS)
contribute
promote
tumor
initiation
progression
CSCs,
while
NDDs
such
as
Alzheimer’s
Parkinson’s
disease,
accelerates
death
impairs
cellular
repair
mechanisms.
Both
scenarios
involve
disruption
delicate
balance
between
pro-oxidant
antioxidant
systems,
leads
chronic
oxidative
stress.
Notably,
CSCs
neurons
display
alterations
redox-sensitive
signaling
pathways,
including
Nrf2
NF-κB,
influence
cell
survival,
proliferation,
differentiation.
Mitochondrial
dynamics
further
illustrate
these
differences:
enhanced
function
supports
adaptability
whereas
impairments
heighten
vulnerability.
Understanding
common
mechanisms
OS-induced
redox
imbalance
may
provide
insights
for
developing
interventions,
addressing
aging
hallmarks,
potentially
mitigating
or
preventing
both